Metraipolis › archive › dc_c13018ada2cb
CRISPR-Cas systems against carbapenem resistance: from proof-of-concept to clinical translation — Europe PMC PMID:41488303
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41488303
- DOI
- 10.3389/fmicb.2025.1725247
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T12:37:27.193Z
- SHA-256 of the archived text
859147d8d2e954a0b3ff91bcabe981a9c28cd733da48023f0cd35ff37706d570- Stable URL of this page
https://metraipolis.com/documento/dc_c13018ada2cb
How to cite
CRISPR-Cas systems against carbapenem resistance: from proof-of-concept to clinical translation — Europe PMC PMID:41488303 — Europe PMC (en), https://europepmc.org/article/MED/41488303 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c13018ada2cb (Metraipolis archive dc_c13018ada2cb, sha256 859147d8d2e954a0b3ff91bcabe981a9c28cd733da48023f0cd35ff37706d570)
BibTeX
@misc{dcc13018ada2cb,
title = {CRISPR-Cas systems against carbapenem resistance: from proof-of-concept to clinical translation — Europe PMC PMID:41488303},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41488303},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c13018ada2cb; sha256 859147d8d2e954a0b3ff91bcabe981a9c28cd733da48023f0cd35ff37706d570},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488303. Agents can read the archived copy with the MCP tool read_document.